Developmental changes in the inhibition of cultured rat uterine cell proliferation by opioid peptides

Cell Proliferation

Volumn 36, Issue 3, 2003, Pages 151-163

  Környei, József L ^a   Vertes Z ^a   Kovacs K A ^a   Gocze P M ^a   Vertes M ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; COLLAGENASE; DYNORPHIN A; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ENKEPHALINAMIDE[2 DEXTRO METHIONINE 5 PROLINE]; EPIDERMAL GROWTH FACTOR; ESTRADIOL; LEUCINE ENKEPHALIN; METENKEPHALIN; MORPHICEPTIN; NALOXONE; OPIATE PEPTIDE; TRYPAN BLUE; TRYPSIN;

AGE DISTRIBUTION; ANIMAL CELL; ARTICLE; CELL COUNT; CELL CULTURE; CELL DENSITY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EFFECT; FEMALE; IC 50; NONHUMAN; ONTOGENY; RAT; UTERUS;

AGING; ANIMALS; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNORPHINS; ENDORPHINS; ENKEPHALIN, METHIONINE; ENKEPHALINS; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FEMALE; INHIBITORY CONCENTRATION 50; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; OVARIECTOMY; RATS; RATS, INBRED STRAINS; RATS, WISTAR; UTERUS;

ANIMALIA; CICONIIFORMES;

EID: 0038052809     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2003.00263.x     Document Type: Article

References (46)

1. AGARWAL D, GLASEL JA (1999) Differential effects of opioid and adrenergic agonists on proliferation in a cultured cell line. Cell Prolif. 32, 215.
2. BAJUSZ S, RÓNAI AZ, SZÉKELY JI, GRÁF L, DUNAI-KOVÁCS Z, BERZÉTEI I (1977) A superactive anti-nociceptive pentapeptide, D-Met2-Pro5-enkephalinamide. FEBS Lett. 76, 91.
3. BARALDI M, GIARRÉ G, SANTI M, FACCHINETTI F, PETRAGLIA F, GENAZZANI AR (1985) Pregnancy-related changes of opiate receptors identified in rat uterine membranes by 3H-naloxone binding. Peptides 6, 971.
4. BARDIN CW, CHEN CLC, MORRIS PL, GERENDAI I, BOITANI C, LIOTTA AS, MARGIORIS A, KRIEGER DT (1987) Pro-opiomelanocortin-derived peptides in testis, ovary, and tissues of reproduction. Rec. Progr. Horm. Res. 43, 1.
5. BURTON K (1956) A study of the condition and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62, 315.
6. CHATURVEDI K, CHRISTOFFERS KH, SINGH K, HOWELLS RD (2000) Structure and regulation of opioid receptors. Biopolymers 55, 334.
7. CHATZAKI E, MARGIORIS AN, MAKRIGIANNAKIS A, CASTANAS E, GEORGOULIAS V, GRAVANIS A (2000) Kappa opioids and TGFbeta1 interact in human endometrial cells. Mol. Hum. Reprod. 6, 602.
8. CHATZAKI E, MAKRIGIANNAKIS A, MARGIORIS AN, KOUIMTZOGLOU E, GRAVANIS A (2001) The fas/FasL apoptotic pathway is involved in kappa-opioid-induced apoptosis of human endometrial stromal cells. Mol. Hum. Reprod. 7, 867.
9. CURTIS SW, WASHBURN T, SEWALL C, DIAUGUSTINE R., LINDZEY J, COUSE JF, KORACH KS (1996) Physicological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc. Natl Acad. Sci. USA 93, 12626.
10. DOWDY S, WEARDEN S (1983) Statistics for research. In: p. 87. New York: John Wiley & Sons Inc.
11. EPIFANOVA OI, BROOKS RF (1994) Negative control of cell proliferation in eukaryotes. Cell Prolif. 27, 373.
12. FISHMAN RB, BRANHAM WS, STRECK RD, SHEEHAN DM (1996) Ontogeny of estrogen receptor messenger ribonucleic acid expression in the postnatal rat uterus. Biol. Reprod. 55, 1221.
13. IGNAR-TROWBRIDGE DM, NELSON KG, BIDWELL MC, CURTIS SW, WASHBURN TF, MCLACHLAN JA, KORACH KS (1992) Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl Acad. Sci. USA 89, 4658.
14. JIN DF, MUFFLY KE, OKULICZ WC, KILPATRICK DL (1988) Estrous-cycle- and pregnancy-related differences in expression of the proenkephalin and proopiomelanocortin genes in the ovary and uterus. Endocrinology 122, 1466.
15. KAYE AM, SHERATZKY D, LINDNER HR (1972) Kinetics of DNA synthesis in immature rat uterus: age dependence and estradiol stimulation. Biochim. Biophys. Acta 261, 475.
16. KIEFFER BL (1999) Opioids: first lessons from knockout mice. Trends. Pharmacol. Sci. 20, 19.
17. KÖRNYEI JL, LI X, LEI ZM, RAO CV (1995) Analysis of epidermal growth factor action in human myometrial smooth muscle cells. J. Endocrinol. 146, 261.
18. KÖRNYEI JL, VÉRTES Z, OSZTER A, KOVÁCS SV, VÉRTES M (1997) Opioid peptides inhibit the estradiol-induced proliferation of cultured rat uterine cells. Eur. J. Pharmacol. 336, 65.
19. KÖRNYEI JL, VÉRTES Z, OSZTER A, KOVÁCS KA, RAO CV, VÉRTES M (1999) Opioid peptides inhibit the action of oestradiol on human myometrial cells in culture. Mol. Hum. Reprod. 5, 565.
20. KÖRNYEI JL, KOVÁCS KA, OSZTER A, VÉRTES Z, KOMLÓSI KM, VÉRTES M (2000) Altered regulation of cell proliferation by opioid peptides in human uterine leiomyoma cells. J. Physiol. (Lond.) 526, 20.
21. KÖRNYEI JL, OSZTER A, KOVÁCS KA, VÉRTES Z, KOMLÓSI KM, GÖCZE PM, VÉRTES M (2001) Anti-mitogenic action of opioid peptides on epidermal growth factor-stimulated uterine cells. Eur. J. Pharmacol. 414, 155.
22. LI WI, SUNG LC, BAZER FW (1991) Immunoreactive methionin-enkephalin secretion by porcine uterus. Endocrinology 128, 21.
23. LOW KG, NIELSEN CP, WEST NB, DOUGLASS J, BRENNER RM, MASLAR IA, MELNER MH (1989) Proenkephalin gene expression in the primate uterus: regulation by estradiol in the endometrium. Mol. Endocrinol. 3, 852.
24. MANECKJEE R., BISWAS R., VONDERHAAR BK (1990) Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res. 50, 2234.
25. MARGIORIS AN (1993) Opioids in neural and non-neural tissues. Trends Endocrinol. Metab. 4, 163.
26. MOGIL JS, PASTERNAK GW (2001) The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53, 381.
27. MUFFLY KE, JIN DF, OKULICZ WC, KILPATRICK DL (1988) Gonadal steroids regulate proenkephalin gene expression in a tissue-specific manner within the female reproductive system. Mol. Endocrinol. 2, 979.
28. NELSON KG, TAKAHASHI T, BOSSERT NL, WALMER DK, MCLACHLAN JA (1991) Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl Acad. Sci. USA 88, 21.
29. ÖRDÖG T, VÉRTES Z, VÉRTES M (1992) Inhibition of oestradiol-induced DNA synthesis by opioid peptides in the rat uterus. Life Sci. 51, 1187.
30. OSZTER A, TÖRÖCSIK B, VÉRTES Z, KÖRNYEI JL, KOVÁCS KA, VÉRTES M (2000a) Regulation of activator protein-1-DNA binding activity by opioid peptides in estrogen-sensitive cells of rat hypothalamus and uterus. Eur. J. Pharmacol. 395, 103.
31. OSZTER A, VÉRTES Z, TÖRÖCSIK B, KÖRNYEI JL, KOVÁCS KA, VÉRTES M (2000b) Anti-estrogenic effect of opioid peptides in rat uterus. J. Steroid Biochem. Mol. Biol. 74, 25.
32. REINSHEID RK, NOTHACKER H, CIVELLI O (2000) The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice. Peptides 21, 901.
33. RÓNAI AZ, BERZÉTEI IP, BAJUSZ. S, SZÉKELY JI (1981) The in vitro pharmacology of D-Met2,Pro5-enkephalinamide. J. Pharm. Pharmacol. 33, 534.
34. SMITH CL (1998) Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol. Reprod. 58, 627.
35. VÉRTES Z, MELEGH G, VÉRTES M, KOVÁCS S (1982) Effect of naloxone and D-met2-pro5-enkephalinamide treatment on the DNA synthesis in the developing rat brain. Life Sci. 31, 49.
36. VÉRTES M, PÁMER, Z, GÁRAI J (1986) On the mechanism of opioid-oestradiol interactions. J. Steroid Biochem. Mol. Biol. 24, 235.
37. VÉRTES Z, KÖRNYEI JL, KOVÁCS S, VÉRTES M (1995) Role of opioid peptides in the regulation of DNA synthesis in immature rat uterus. Eur. J. Pharmacol. 291, 115.
38. VÉRTES Z, KÖRNYEI JL, KOVÁCs S, VÉRTES M (1996) Opioids regulate cell proliferation in the developing rat uterus: effects during the period of sexual maturation. J. Steroid Biochem. Mol. Biol. 59, 173.
39. VÉRTES Z, SÁNDOR A, KOVÁCS KA, OSZTER A, KÖRNYEI JL, KOVÁCS S, VÉRTES M (2000) Epidermal growth factor influenced by opioid peptides in immature rat uterus. J. Endocrinol. Invest. 23, 502.
40. WAHLSTROM T, LAATIKAINEN T, SALMINEN K, LEPPALUOTO J (1985) Immonureactive β-endorphin is demonstrable in the secretory but not in the proliferative endometrium. Life Sci. 36, 987.
41. WEI LN, LOH HH (2002) Regulation of opioid receptor expression. Curr. Opin. Pharmacol. 2, 69.
42. WILSON RP, MCLAUCHLIN PJ, LANG CM, ZAGON IS (2000) The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin. Cell Prolif. 33, 63.
43. WITTERT G, HOPE P, PYLE D (1996) Tissue distribution of opioid receptor gene expression in the rat. Biochem. Biophys. Res. Commun. 218, 877.
44. ZAGON IS, MCLAUGHLIN PJ (1991) Zeta, a growth-related opioid receptor in developing rat cerebellum: identification and characterization. Brain Res. 551, 28.
45. ZAGON IS, VERDERAME MF, MCLAUGHLIN PJ (2002) The biology of the opioid growth factor receptor (OGFr). Brain Res. Rev. 38, 351.
46. ZHU Y, PINTAR JE (1998) Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. Biol. Reprod. 59, 925.